Recruitment

Recruitment Status
Active, not recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Arteriosclerosis
  • Cardiovascular Diseases
  • Coronary (Artery) Disease
  • Ischemic Heart Disease
  • Stenotic Coronary Lesion
Type
Interventional
Phase
Not Applicable
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: 1:1 RandomizationMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

This study is a pre-Market, prospective, multi-center, open-label, randomized controlled trial. Subjects will be 1:1 randomized and followed through 5 Years (screen, implant procedure(including post-procedure assessment),30-Day, 6 Months, 9 Months (primary endpoint_LLL), and annual assessments from ...

This study is a pre-Market, prospective, multi-center, open-label, randomized controlled trial. Subjects will be 1:1 randomized and followed through 5 Years (screen, implant procedure(including post-procedure assessment),30-Day, 6 Months, 9 Months (primary endpoint_LLL), and annual assessments from 1-5 years).

Tracking Information

NCT #
NCT03466151
Collaborators
Not Provided
Investigators
Principal Investigator: Yongjian Wu, MD Fuwai Hospital, Chinese Academy of Medical Science
About Us
Innovation
Privacy
Terms
Copyright
Get Well Soon © Copyright 2024